Hening Lin to Enzyme Inhibitors
This is a "connection" page, showing publications Hening Lin has written about Enzyme Inhibitors.
Connection Strength
1.568
-
High-Throughput Enzyme Assay for Screening Inhibitors of the ZDHHC3/7/20 Acyltransferases. ACS Chem Biol. 2021 08 20; 16(8):1318-1324.
Score: 0.559
-
Sirtuin inhibitors as anticancer agents. Future Med Chem. 2014 May; 6(8):945-66.
Score: 0.337
-
Thiosuccinyl peptides as Sirt5-specific inhibitors. J Am Chem Soc. 2012 Feb 01; 134(4):1922-5.
Score: 0.288
-
Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer. J Med Chem. 2021 10 28; 64(20):15280-15296.
Score: 0.141
-
N-Myristoyltransferase as a Glycine and Lysine Myristoyltransferase in Cancer, Immunity, and Infections. ACS Chem Biol. 2020 07 17; 15(7):1747-1758.
Score: 0.129
-
A fluorogenic assay for screening Sirt6 modulators. Org Biomol Chem. 2013 Aug 28; 11(32):5213-6.
Score: 0.080
-
Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer. Oncogene. 2021 03; 40(9):1644-1658.
Score: 0.034